BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34204474)

  • 1. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
    Kähkönen TE; Halleen JM; Bernoulli J
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into immuno-oncology drug development landscape with focus on bone metastasis.
    Kähkönen TE; Halleen JM; MacRitchie G; Andersson RM; Bernoulli J
    Front Immunol; 2023; 14():1121878. PubMed ID: 37475868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Contribution of the Immune System in Bone Metastasis Pathogenesis.
    Xiang L; Gilkes DM
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
    Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Cells in Metastasis.
    Swierczak A; Pollard JW
    Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31548218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis and the metastatic niche.
    Ren G; Esposito M; Kang Y
    J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
    Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
    Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?
    You H; Baluszek S; Kaminska B
    Front Immunol; 2019; 10():1941. PubMed ID: 31481958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
    Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
    Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation.
    Liu C; Wang M; Xu C; Li B; Chen J; Chen J; Wang Z
    J Immunol Res; 2021; 2021():8970173. PubMed ID: 34877360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lymph node pre-metastatic niche.
    Sleeman JP
    J Mol Med (Berl); 2015 Nov; 93(11):1173-84. PubMed ID: 26489604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model for the immune-mediated theory of metastasis.
    Rhodes A; Hillen T
    J Theor Biol; 2019 Dec; 482():109999. PubMed ID: 31493486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.
    Asiry S; Kim G; Filippou PS; Sanchez LR; Entenberg D; Marks DK; Oktay MH; Karagiannis GS
    Front Immunol; 2021; 12():654877. PubMed ID: 33927723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Modulation of Metastatic Niche Formation in the Bone.
    Cheng X; Wang Z
    Front Immunol; 2021; 12():765994. PubMed ID: 34745140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
    Podar K; Jager D
    Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis.
    Monteran L; Ershaid N; Sabah I; Fahoum I; Zait Y; Shani O; Cohen N; Eldar-Boock A; Satchi-Fainaro R; Erez N
    Sci Rep; 2020 Aug; 10(1):13838. PubMed ID: 32796899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis.
    Luo G; He Y; Zhao Q; Yu X
    Recent Pat Anticancer Drug Discov; 2017; 12(3):221-233. PubMed ID: 28595538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms, Diagnosis and Treatment of Bone Metastases.
    Ban J; Fock V; Aryee DNT; Kovar H
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.
    Owen KL; Parker BS
    Mol Immunol; 2019 Jun; 110():57-68. PubMed ID: 29191489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.